Gilead’s Sandra Patterson has “decided to leave the company” after two years in the SVP corporate controller and chief ...

Sutro Biopharma is undergoing a seismic shake-up —jettisoning its CEO, half of its workforce, its lead candidate and its manufacturing facility in a major bid to save cash.

The National Institutes of Health (NIH) is continuing its grant-canceling spree, allegedly targeting dozens of research ...

Synthetic biology specialist GRO Biosciences started exploring strategic alternatives about six months after raising a series ...

The result suggests that the protein made by the gene, known as Nwd1, and other molecules it interacts with could be ...

ImmunoPrecise Antibodies has secured a collaboration with an undisclosed “leading biotech” to discover new antibody-drug ...

Samsung is backing Alzheimer’s disease blood test developer C2N Diagnostics, with $10 million to help scale up its commercial ...

Bindman, M.D., a professor at the University of California, San Francisco (UCSF) medical school, has spent well over a decade ...

Sotio Biotech is pushing deeper into bispecific antibody-drug conjugates (ADC), taking up its option to use Synaffix’s ...

Takeda’s revamped R&D strategy means the drugmaker’s oncology leaders are prioritizing work in tumors across thoracic, ...

With MeiraGTx eyeing up how to take the drug through phase 3 and onto commercialization, Hologen has stepped in. The ...

Eye surgery specialist BVI Medical announced this week it has raised $1 billion in new financing as it looks to boost its global intraocular lens business with “several new product launch | BVI said ...